Peipei Liu
Impact in
- Biotechnology top 0.5%
- Marine Sponges and Natural Products
- Pharmacology top 0.5%
- Microbial Natural Products and Biosynthesis
- Fungal Biology and Applications
- Cholinesterase and Neurodegenerative Diseases
Papers in
- Pharmacology 35
- Microbial Natural Products and Biosynthesis 32
- Fungal Biology and Applications 18
- Epidemiology 32
- Respiratory viral infections research 7
- Co-authors
- Weiming Zhu (34 shared papers)Jian‐Sheng Kang (4 shared papers)Yi Xie (3 shared papers)Xiao‐Yan Meng (3 shared papers)Peng Fu (12 shared papers)Yi Wang (9 shared papers)Kui Hong (7 shared papers)Jinkai Zheng (5 shared papers)
- Journals
- Journal of Natural Products (10 papers)Biosafety and Health (4 papers)Archives of Virology (4 papers)Frontiers in Endocrinology (4 papers)Marine Drugs (3 papers)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Peipei Liu
182 papers receiving 4.3k citations
Peipei Liu's Hit Papers
Peers
Comparison fields: 5 of 158
- Biotechnology 795
- Pharmacology 1.4k
- Toxicology 103
- Biological Psychiatry 75
- Infectious Diseases 460
Countries citing papers authored by Peipei Liu
This map shows the geographic impact of Peipei Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peipei Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peipei Liu more than expected).
Fields of papers citing papers by Peipei Liu
This network shows the impact of papers produced by Peipei Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peipei Liu. The network helps show where Peipei Liu may publish in the future.
Co-authors
The 25 scholars most cited alongside Peipei Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 200 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | History and progress of hypotheses and clinical trials for Alzheimer’s disease Hit paper breakdown → | 2019 | 503 |
| 2 | 2020 | 146 | |
| 3 | 2015 | 116 | |
| 4 | 2013 | 111 | |
| 5 | 2011 | 110 | |
| 6 | 2011 | 104 | |
| 7 | 2011 | 91 | |
| 8 | 2011 | 90 | |
| 9 | 2009 | 87 | |
| 10 | 2009 | 82 | |
| 11 | 2019 | 77 | |
| 12 | 2008 | 68 | |
| 13 | 2009 | 68 | |
| 14 | 2021 | 66 | |
| 15 | 2013 | 66 | |
| 16 | 2011 | 64 | |
| 17 | 2010 | 63 | |
| 18 | 2014 | 62 | |
| 19 | 2011 | 61 | |
| 20 | 2011 | 59 |
About Peipei Liu
Peipei Liu is a scholar working on Pharmacology, Epidemiology, Infectious Diseases, Molecular Biology and Cardiology and Cardiovascular Medicine, having authored 200 papers that have together received 4.3k indexed citations. Recurring topics across this work include Microbial Natural Products and Biosynthesis (32 papers), Marine Sponges and Natural Products (21 papers), Fungal Biology and Applications (18 papers), Viral Infections and Immunology Research (14 papers), Viral gastroenteritis research and epidemiology (13 papers), SARS-CoV-2 and COVID-19 Research (13 papers), COVID-19 Clinical Research Studies (7 papers) and Respiratory viral infections research (7 papers). The work is most often cited by research in Biotechnology (795 citations), Pharmacology (1.4k citations), Toxicology (103 citations), Biological Psychiatry (75 citations) and Infectious Diseases (460 citations). Peipei Liu has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Weiming Zhu, Jian‐Sheng Kang, Yi Xie, Xiao‐Yan Meng, Peng Fu, Yi Wang, Kui Hong, Jinkai Zheng, Yi Wang and Wei Wang. Their work appears in journals such as Journal of Natural Products, Biosafety and Health, Archives of Virology, Frontiers in Endocrinology and Marine Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.